Information Journal Paper
APA:
Copy. (2017). Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: phase I/IIa studies. STEM CELLS, 35(1), 248-255. SID. https://sid.ir/paper/772784/en
Vancouver:
Copy. Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: phase I/IIa studies. STEM CELLS[Internet]. 2017;35(1):248-255. Available from: https://sid.ir/paper/772784/en
IEEE:
Copy, “Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: phase I/IIa studies,” STEM CELLS, vol. 35, no. 1, pp. 248–255, 2017, [Online]. Available: https://sid.ir/paper/772784/en